|
Mechanistic insight of cyclin-dependent kinase 5 in modulating lung cancer growth
G. M. Shazzad Hossain Prince1, Tsung-Ying Yang2, Ho Lin3, Mei-Chih Chen4
1 Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan
2 Department of Internal Medicine, Division of Chest Medicine, Taichung Veterans General Hospital, Taichung; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
3 Department of Life Sciences; Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan
4 Department of Nursing, Asia University; Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
Correspondence Address:
Prof. Ho Lin
Department of Life Sciences, National Chung Hsing University, Taichung 40227
Taiwan
Prof. Mei-Chih Chen
Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung 40447
Taiwan
 Source of Support: This study was supported by the Ministry of Science and Technology, Taiwan (106-2320-B-005-002-MY3/108-2911-I-005-509 to H. L.), the grant of NCHU ENABLE Center (108-16 to H. L.), Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU-1097615 to H. L.), and Tungs' Taichung MetroHarbor Hospital (TTMHH-NCHULS107004 to H. L.)., Conflict of Interest: None  | 3 |
DOI: 10.4103/CJP.CJP_67_19
|
|
Lung harbors the growth of primary and secondary tumors. Even though numerous factors regulate the complex signal transduction and cytoskeletal remodeling toward the progression of lung cancer, cyclin-dependent kinase 5 (Cdk5), a previously known kinase in the central nervous system, has raised much attention in the recent years. Patients with aberrant Cdk5 expression also lead to poor survival. Cdk5 has already been employed in various cellular processes which shape the fate of cancer. In lung cancer, Cdk5 mainly regulates tumor suppressor genes, carcinogenesis, cytoskeletal remodeling, and immune checkpoints. Inhibiting Cdk5 by using drugs, siRNA or CRISP-Cas9 system has rendered crucial therapeutic advantage in the combat against lung cancer. Thus, the relation of Cdk5 to lung cancer needs to be addressed in detail. In this review, we will discuss various cellular events modulated by Cdk5 and we will go further into their underlying mechanism in lung cancer.
|
